Hims is expanding men’s telehealth with testosterone replacement therapy (TRT) for cisgender men, offering a path from home screening to two injectable options or an oral pill. Because testosterone is a controlled substance, care includes live video visits before a prescription and during follow-up rather than a questionnaire-only process.
Screening uses a ‘Tasso’ device worn on the upper arm to collect a small capillary sample without a standard blood draw. A lab review covers 21 biomarkers, including testosterone and thyroid hormones, allowing clinicians to weigh symptoms and medical history before recommending TRT or another next step.
Live video visits and lab work move online testosterone care closer to a medical evaluation than a lifestyle pitch. The ‘Tasso’ home test widens access for men who might otherwise skip an in-person screening while setting a stricter expectation for telehealth hormone care.
Image Credit: Hims
Why This Trend Is Growing
- Clinician-guided Hormone Telehealth
- Hybrid digital care models that combine lab diagnostics with live clinician oversight create room for more trusted virtual treatments in regulated health categories.
- At-home Biomarker Testing
- Capillary collection devices and broad biomarker panels are making complex diagnostics more convenient, enabling earlier intervention outside traditional clinics.
- Regulated Digital Therapeutics
- Telehealth platforms are evolving beyond low-friction questionnaires as controlled treatments require stronger compliance, monitoring, and patient safety infrastructure.
Industries Being Reshaped
- Men’s Health
- Personalized hormone care and discreet home testing are reshaping how men access preventive, diagnostic, and ongoing treatment services.
- Telemedicine
- Video-based prescribing workflows for controlled therapies signal a shift toward higher-acuity virtual care with deeper clinical accountability.
- Diagnostics
- Home sample collection paired with multi-marker lab analysis expands the market for remote testing technologies that support medical-grade decision-making.
